Presence of excess tetrahydrobiopterin during nitric oxide production from inducible nitric oxide synthase in LPS-treated rat aorta

Life Sciences

Volumn 65, Issue 26, 1999, Pages 2769-2779

  Shimizu, Shunichi ^a   Ishii, Masakazu ^a   Kawakami, Yutaka ^a   Kiuchi, Yuji ^a   Momose, Kazutaka ^a   Yamamoto, Toshinori ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Lipopolysaccharide; Nitric oxide; Rat aorta; Tetrahydrobiopterin

Indexed keywords

2,4 DIAMINO 6 HYDROXYPYRIMIDINE; AMINOGUANIDINE; ARGININE; CYTOKINE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LIPOPOLYSACCHARIDE; MESSENGER RNA; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PYRIMIDINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; TETRAHYDROBIOPTERIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SYNTHESIS;

EID: 0033585141     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00545-7     Document Type: Article

References (44)

1. R.M.J. Palmer, D.S. Ashton and S. Moncada, Nature 333 664-666 (1988).
2. B. Mayer, K. Schmidt, P. Humbert and E. Böhme. Biochem. Biophys. Res. Commun. 164 678-685 (1989).
3. U. Förstermann, J.S. Pollock, H.H.H.W. Schmidt, M. Heller and F. Murad, Proc. Natl. Acad. Sci. USA 88 1788-1792 (1991).
4. J.S. Pollock, U. Förstermann, J.A. Mitchell, T.D. Warner, H.H.H.W. Schmidt, M. Nakane and F. Murad, Proc. Natl. Acad. Sci. USA 88 10480-10484 (1991).
5. R. Busse and A. Mulsch, FEBS Lett. 275 87-90 (1990).
6. S.S. Gross and R. Levi, J. Biol. Chem. 267 25722-25729 (1992).
7. L.C. Denlinger, P.L. Fisette, K.A. Garis, G. Kwon, A. Vazquez-Torres, A.D. Simon, B. Nguyen, R.A. Proctor, P.J. Bertics and J.A. Corbett, J. Biol. Chem. 271 337-342 (1996).
8. J. Gao, D.C. Morrison, T.J. Parmely, S.W. Russell and W.J. Murphy, J. Biol. Chem. 272 1226-1230 (1997).
9. D.D. Rees, Biochem. Soc. Trans. 23 1025-1029 (1995).
10. C. Szabo, A.L. Salzman and H. Ischiropoulos, FEBS Lett. 363 235-238 (1995).
11. S. Cuzzocrea, B. Zingarelli, M. O'Connor, A.L. Salzman and C. Szabo, Br. J. Pharmacol. 123 525-537 (1998).
12. Y.K. Youn, C. LaLonde and R. Demling, Circ. Shock 35 245-249 (1991).
13. J.M. McCord, New Horiz. 1 70-76 (1993).
14. J.S. Beckman, T.W. Beckman, J. Chen, P.A. Marshall and B.A. Freeman, Proc. Natl. Acad. Sci. USA 87 1620-1624 (1990).
15. R. Radi, J.S. Beckman, K.M. Bush, and B.A Freeman, Arch. Biochem. Biophys. 288 481-487 (1991).
16. A.A. Noronha-Dutra, M.M. Epperlein and N. Woolf, FEBS Lett. 321 59-62 (1993).
17. R.E. Huie and S. Padmaja, Free Radic. Res. Commun. 18 195-199 (1993).
18. J.P. Crow and J.S. Beckman, Adv. Pharmacol. 34 17-43 (1995).
19. N.W. Kooy, J.A. Royall, Y.Z. Ye, D.R. Kelly and J.S. Beckman, Am. J. Respir. Crit. Care. Med. 151 1250-1254 (1995).
20. C. Szabo, Shock 6 79-88 (1996).
21. S. Cuzzocrea, B. Zingarelli, P. Hake, A.L. Salzman and C. Szabo, Free Radic. Biol. Med. 24 450-459 (1998).
22. N.S. Kwon, C.F. Nathan and D.J. Stuehr, J. Biol. Chem. 264 20496-20501 (1989).
23. M.A. Tayeh and M.A. Marletta, J. Biol. Chem. 264 19654-19658 (1989).
24. D.K. Nakayama, D.A. Geller, M. Di Silvio, G. Bloomgarden, P. Davies, B.R. Pitt, K. Hatakeyama, H. Kagamiyama, R.L. Simmons and T.R. Billiar, Am. J. Physiol. 266 L455-L460 (1994).
25. G. Schoedon, M. Schneemann, S. Hofer, L. Guerrero, N. Blau and A. Schaffner, Eur. J. Biochem. 213 833-839 (1993).
26. J.M. Harlan, L.A. Harker, M.A. Reidy, C.M. Gajdusek, S.M. Schwartz and G.E. Striker, Lab. Invest. 48 269-274 (1983).
27. W. Chamulitrat, N.V. Skrepnik and J.J. Spitzer, Shock 5 217-222 (1996).
28. C.A. Wakulich and B.L. Tepperman, Eur. J. Pharmacol. 29 333-341 (1997).
29. M. Ishii, S. Shimizu, K. Momose and T. Yamamoto, Pharmacol. Toxicol. 82 280-286 (1998).
30. S. Shimizu, M. Ishii, Y. Kawakami, K. Momose and T. Yamamoto, Life Sci. 63 1585-1592 (1998).
31. M. Ishii, S. Shimizu, K. Momose and T. Yamamoto, J. Cardiovasc. Pharmacol. 33 295-300 (1999).
32. S. Kojima, K. Nimura, H. Komatsu, T. Taguchi and H. Iizuka, Anticancer Res. 17 929-937 (1997).
33. K. Koshimura, Y. Murakami, J. Tanaka and Y. Kato, J. Neurosci. Res. 54 664-672 (1998).
34. T. Fukushima and J.C. Nixon, Anal. Biochem. 102 176-188 (1980).
35. G. Schoedon, M. Schneemann, S. Hofer, L. Guerrero, N. Blau and A. Schaffner, Eur. J. Biochem. 213 833-839 (1993).
36. H. Moritoki, H. Ueda, T. Yamamoto, T. Hisayama and S. Takeuchi, Br. J. Pharmacol. 102 841-846 (1991).
37. M. Niwa, Y. Tsutsumishita, Y. Kawai, H. Takahara, N. Nakamura, S. Futaki, Y. Takaishi, W. Kondoh and H. Moritoki, Biochem. Biophys. Res. Commun. 224 579-585 (1996).
38. C. Szabo, S. Cuzzocrea, B. Zingarelli, M. O'Connor and A.L. Salzman, J. Clin. Invest. 100 723-735 (1997).
39. H. Maeda and T. Akaike, Biochemistry 63 854-865 (1998).
40. S. Kojima, S. Ona, I. Iizuka, T. Arai, H. Mori and K. Kubota, Free Radic. Res. 23 419-430 (1995).
41. A.L. Kleschyov, B. Muller, C. Schott and J. Stoclet, Br. J. Pharmacol. 124 623-626 (1998).
42. B. Brüne, C. Götz, U.K. MeBmer, K. Sandau, M-R. Hirvonen and E.G. Lapetina, J. Biol. Chem. 272 7253-7258 (1997).
43. P. Jorens, F. Van Overveld, P. Vermeire, H. Bult and A. Herman, Eur. J. Pharmacol. 224 7-12 (1992).
44. J. MacMicking, Q.-W. Xie and C. Nathan, Annu. Rev. Immunol. 15 323-350 (1997).